You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Cash Flow    
Bal Pharma Ltd.
 
BSE Code 524824
ISIN Demat INE083D01012
Book Value 62.40
NSE Code BALPHARMA
Dividend Yield(%) 0.97
Market Cap(Million) 1626.84
P/E(X) 26.35
EPS(Rs.) 3.91
Face Value(Rs.) 10  
Type
(Rs. in Million)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Profit Before Tax47.4991.8341.03-135.29-2.02
Adjustment214.37171.54211.43190.08174.06
Changes In working Capital-275.2516.61-27.99179.37-70.70
Cash Flow after changes in Working Capital-13.39279.97224.47234.15101.34
Cash Flow from Operating Activities-18.44267.96223.35232.4377.58
Cash Flow from Investing Activities-221.82-94.85-55.35-47.05-80.44
Cash Flow from Financing Activities244.00-172.22-166.32-199.730.14
Net Cash Inflow / Outflow3.740.891.68-14.35-2.72
Opening Cash & Cash Equivalents11.1310.248.5924.3627.09
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00-0.04-1.420
Closing Cash & Cash Equivalent14.8711.1310.238.5924.36